Recently acquired HCV infection in men who have sex with men in Germany in the direct‐acting antivirals era and during the COVID ‐19 pandemic
HIV Medicine · 2024
DOI: 10.1111/hiv.13651 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2024. Verfasst von Patrick Ingiliz und 14 weiteren Autor:innen. Beteiligte Einrichtung: ZIBP, Berlin, Germany. Hauptthemen laut MEDLINE: Homosexuality, Male, Antiviral Agents, COVID-19, HIV Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Introduction
Direct‐acting antivirals (DAAs) are key to eliminating hepatitis C virus (HCV). In men who have sex with men (MSM) with HIV co‐infection, recently acquired HCV infection is common. Sexual practices and reinfection rates may hamper micro‐elimination despite high treatment rates.
Methods
The cohort included MSM with recently acquired HCV infection from 2014 to 2021. The patients' demographic, clinical, behavioural, and laboratory data and treatment and reinfection outcomes were documented.
Results
A total of 237 men with recently acquired HCV infection were included: 216 (91%) had HIV. The median age was 46 years (interquartile range [IQR] 39–52), and the median CD4 count was 660/mm 3 (IQR 527–835). The annual incidence of recently acquired HCV remained between 0.28% and 0.43% but dropped to 0.02% in 2021 during the COVID pandemic, almost reaching micro‐elimination. The reinfection incidence was 15.5 per 100 patient‐years (95% confidence interval 12.6–18.8), and reinfection was associated with the use of crystal methamphetamine ( p = 0.032) and ketamine ( p = 0.042). In total, 31.3% had multiple reinfections, and four reinfections occurred in users of pre‐exposure prophylaxis.
Conclusions
High treatment and cure rates did not lead to HCV elimination. A change in sexual behaviour, potentially imposed by COVID‐19 restrictions, led to micro‐elimination in the NoCo cohort. As recently acquired HCV is prevalent in MSM with and without HIV, surveillance is necessary to consolidate elimination goals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ZIBP, Berlin, Germany.
- APHP Henri-Mondor University Hospital, INSERM U955, Créteil, France.
- Infektiologikum, Frankfurt, Germany.
- ICH Study Center, Hamburg, Germany.
- Center for HIV and Hepatogastroenterology, Düsseldorf, Germany.
- Centrum für Interdisziplinäre Medizin, Münster, Germany.
ORCID-Profile: Michael Sabranski
Förderung
- Gilead Sciences
Zitieren
APA
Ingiliz, P., Lutz, T., Schewe, K., Baumgarten, A., Krznaric, I., Mauss, S., Christensen, S., Bickel, M., Schmidt, A. J., Sabranski, M., He, F., Jain, S., Martin, N. K., Rockstroh, J. K., & Boesecke, C. (2024). Recently acquired HCV infection in men who have sex with men in Germany in the direct‐acting antivirals era and during the COVID ‐19 pandemic. HIV Medicine. https://doi.org/10.1111/hiv.13651
Vancouver
Ingiliz P, Lutz T, Schewe K, Baumgarten A, Krznaric I, Mauss S, et al. Recently acquired HCV infection in men who have sex with men in Germany in the direct‐acting antivirals era and during the COVID ‐19 pandemic. HIV Medicine. 2024. doi:10.1111/hiv.13651
BibTeX
@article{Ingiliz2024,
author = {Ingiliz, Patrick and Lutz, Thomas and Schewe, Knud and Baumgarten, Axel and Krznaric, Ivanka and Mauss, Stefan and Christensen, Stefan and Bickel, Markus and Schmidt, Axel J and Sabranski, Michael and He, Feng and Jain, Sonia and Martin, Nastasha K and Rockstroh, Jürgen K and Boesecke, Christoph},
title = {Recently acquired HCV infection in men who have sex with men in Germany in the direct‐acting antivirals era and during the COVID ‐19 pandemic},
journal = {HIV Medicine},
year = {2024},
doi = {10.1111/hiv.13651}
}
EUVIMED